Fig. 5From: CD11c-specific bio-nanocapsule enhances vaccine immunogenicity by targeting immune cellsProliferation of OVA-specific CTL by immunization with α-DC-ZZ-BNC-OVA. a After 7 days from subcutaneous injection, C57BL/6 mice were sacrificed, and the splenocytes were isolated and stained with APC-labeled H-2kb OVA tetramer and FITC-labeled α-CD8 IgG. b Statistic analysis of the CTL proliferation (N = 3, mean ± SEM). *p < 0.01Back to article page